检验医学 ›› 2017, Vol. 32 ›› Issue (11): 1070-1074.DOI: 10.3969/j.issn.1673-8640.2017.011.029

• 综述与讲座 • 上一篇    

Semaphorin 3A检测对肾损伤的诊断价值

张艺欣1, 魏殿军2, 宁莉2   

  1. 1.天津医科大学医学检验学院,天津 300203
    2.天津医科大学第二医院检验科,天津 300211
  • 收稿日期:2017-02-15 出版日期:2017-11-30 发布日期:2017-12-07
  • 作者简介:null

    作者简介:张艺欣,女,1991年生,学士,主要从事急性肾损伤实验室诊断研究。

  • 基金资助:
    天津市卫生和计划生育委员会科技基金项目(2015KZ101)

Semaphorin 3A detection in the diagnosis of kidney injury

ZHANG Yixin1, WEI Dianjun2, NING Li2   

  1. 1. School of Medical Laboratory,Tianjin Medical University,Tianjin 300203,China
    2. Department of Clinical Laboratory,the Second Hospital of Tianjin Medical University,Tianjin 300211,China
  • Received:2017-02-15 Online:2017-11-30 Published:2017-12-07

摘要:

Semaphorin家族是一组控制血管、器官、细胞迁移、细胞因子释放及轴突生长的系列蛋白,Semaphorin 3A(Sema 3A)是其中研究最为透彻的家族成员之一。近年来,多项研究表明Sema 3A是急性肾损伤的早期诊断标志物。Sema 3A作为新的急、慢性肾损伤标志物已被证实,但尚需大量的研究数据来确定其诊断性能。Sema 3A是未来临床治疗方面的一个非常有前途的靶点,是肾损伤研究的热点之一。文章对Sema 3A这一肾损伤诊断标志物作一综述。

关键词: Semaphorin 3A, 急性肾损伤, 生物学标志物

Abstract:

Semaphorin family is a series of proteins which control blood vessels and organs,cell migration,cell factor and axon growth. Among this family,semaphorin 3A(Sema 3A) is a member being studied thoroughly. Recently,several studies show Sema 3A is a new biomarker for the early diagnosis of acute kidney injury. It has been confirmed as a new marker both for acute kidney injury and chronic kidney diseases,and a large amount of data are needed to support its diagnostic performance. Furthermore,Sema 3A is a new and hot research object as a promising target for future clinical treatment in kidney injury. This review focuses on Sema 3A-a new kidney injury diagnosis biomarker.

Key words: Semaphorin 3A, Acute kidney injury, Biomarker

中图分类号: